Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)

吡格列酮 脂肪性肝炎 脂肪肝 非酒精性脂肪肝 代谢综合征 过氧化物酶体增殖物激活受体 罗格列酮 胰岛素抵抗 脂质代谢 内科学 医学 内分泌学 生物 2型糖尿病 糖尿病 受体 疾病
作者
Yuan-ye Qiu,Jing Zhang,Fanyi Zeng,Yi Zhun Zhu
出处
期刊:Pharmacological Research [Elsevier BV]
卷期号:192: 106786-106786 被引量:111
标识
DOI:10.1016/j.phrs.2023.106786
摘要

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease phenotypes which start with simple steatosis and lipid accumulation in the hepatocytes - a typical histological lesions characteristic. It may progress to non-alcoholic steatohepatitis (NASH) that is characterized by hepatic inflammation and/or fibrosis and subsequent onset of NAFLD-related cirrhosis and hepatocellular carcinoma (HCC). Due to the central role of the liver in metabolism, NAFLD is regarded as a result of and contribution to the metabolic abnormalities seen in the metabolic syndrome. Peroxisome proliferator-activated receptors (PPARs) has three subtypes, which govern the expression of genes responsible for energy metabolism, cellular development, inflammation, and differentiation. The agonists of PPARα, such as fenofibrate and clofibrate, have been used as lipid-lowering drugs in clinical practice. Thiazolidinediones (TZDs) - ligands of PPARγ, such as rosiglitazone and pioglitazone, are also used in the treatment of type 2 diabetes (T2D) with insulin resistance (IR). Increasing evidence suggests that PPARβ/δ agonists have potential therapeutic effects in improving insulin sensitivity and lipid metabolism disorders. In addition, PPARs ligands have been considered as potential therapeutic drugs for hypertension, atherosclerosis (AS) or diabetic nephropathy. Their crucial biological roles dictate the significance of PPARs-targeting in medical research and drug discovery. Here, it reviews the biological activities, ligand selectivity and biological functions of the PPARs family, and discusses the relationship between PPARs and the pathogenesis of NAFLD and metabolic syndrome. This will open new possibilities for PPARs application in medicine, and provide a new idea for the treatment of fatty liver and related diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小稻草人应助杨春末采纳,获得10
1秒前
小杨发布了新的文献求助10
1秒前
meme发布了新的文献求助10
2秒前
mgr完成签到,获得积分10
2秒前
hata233发布了新的文献求助10
2秒前
Orange应助文艺的冬卉采纳,获得10
3秒前
喵叽完成签到,获得积分20
4秒前
动人的珩发布了新的文献求助30
4秒前
ccc发布了新的文献求助10
5秒前
5秒前
小魏完成签到,获得积分10
6秒前
宁静致远完成签到,获得积分10
6秒前
战战完成签到,获得积分10
7秒前
553599712完成签到,获得积分10
9秒前
9秒前
9秒前
pluto完成签到,获得积分10
9秒前
木木完成签到,获得积分0
10秒前
CDH完成签到,获得积分10
10秒前
正直夜安完成签到 ,获得积分10
10秒前
爱吃蜂蜜发布了新的文献求助10
10秒前
风吹而过发布了新的文献求助30
10秒前
HelloJoey完成签到,获得积分10
11秒前
ding应助meme采纳,获得10
11秒前
Wsyyy完成签到 ,获得积分10
11秒前
冰儿菲菲完成签到,获得积分10
12秒前
王小凡完成签到 ,获得积分10
12秒前
12秒前
来弄完成签到,获得积分10
13秒前
zwjy完成签到,获得积分10
13秒前
HelloJoey发布了新的文献求助10
13秒前
清修发布了新的文献求助10
14秒前
王丹宁发布了新的文献求助10
15秒前
溆玉碎兰笑完成签到 ,获得积分10
15秒前
居然是我完成签到,获得积分10
16秒前
疯狂大脑壳完成签到,获得积分10
16秒前
TQ完成签到,获得积分10
16秒前
忙碌的数学人完成签到,获得积分10
16秒前
鲤鱼怀绿完成签到,获得积分10
17秒前
能干的邹完成签到 ,获得积分10
17秒前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Social Research Methods (4th Edition) by Maggie Walter (2019) 2390
A new approach to the extrapolation of accelerated life test data 1000
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
Atlas of Interventional Pain Management 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4009004
求助须知:如何正确求助?哪些是违规求助? 3548719
关于积分的说明 11299835
捐赠科研通 3283284
什么是DOI,文献DOI怎么找? 1810333
邀请新用户注册赠送积分活动 886115
科研通“疑难数据库(出版商)”最低求助积分说明 811259